Logo image of EMBC

EMBECTA CORP (EMBC) Stock Analyst Ratings

NASDAQ:EMBC - Nasdaq - US29082K1051 - Common Stock - Currency: USD

14.1  -0.31 (-2.15%)

After market: 14.1 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to EMBC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 21.47. This target is 52.28% above the current price.
EMBC was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EMBC.
In the previous month the buy percentage consensus was at a similar level.
EMBC was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
EMBC Historical Analyst RatingsEMBC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 14.1018.3820.4021.4727.30 - 30.37% 44.68% 52.28% 93.62%
EMBC Current Analyst RatingEMBC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-11-27 BTIG Upgrade Neutral -> Buy
2024-07-15 Morgan Stanley Maintains Underweight -> Underweight
2024-05-10 Morgan Stanley Maintains Underweight -> Underweight
2023-11-22 Morgan Stanley Maintains Underweight -> Underweight
2023-10-18 Morgan Stanley Maintains Underweight -> Underweight
2023-08-24 Morgan Stanley Maintains Underweight -> Underweight
2023-07-18 Morgan Stanley Maintains Underweight -> Underweight
2023-05-15 Morgan Stanley Maintains Underweight -> Underweight
2023-01-06 Morgan Stanley Downgrade Equal-Weight -> Underweight
2022-12-21 Morgan Stanley Maintains Equal-Weight
2022-10-11 Morgan Stanley Maintains Equal-Weight
2022-09-08 BTIG Initiate Neutral
2022-08-16 Morgan Stanley Maintains Equal-Weight
2022-08-01 Morgan Stanley Initiate Equal-Weight
2022-06-21 B of A Securities Initiate Underperform